drugset / Trial / NCT00582010

Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation

NCT00582010

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver injury associated with the restoration of blood flow. The premise of the current study is provided by previous studies which document a protective effect of inhaled nitric oxide in this clinical setting.

Timeline

Start
2008-04
Primary completion
2009-03
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 80 ppm Inhaled

Indications